Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Midatech Pharma US Inc. (DARA) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $1.48 Metrics
OS: 19.8 M -48 % ROE
Market cap: $29.2 M
Net cash: $4.58 M $0.23 per share
EV: $24.7 M

 
TTM Valuation
EBITDA ($9.5) M
EBIT ($10.2) M
EPS ($0.04)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07
Revenues1.90.40.10.00.01.90.00.0
            Revenue growth349.9%681.9%  -100.0%  -100.0%
Cost of goods sold0.40.20.00.00.02.80.00.0
Gross profit1.40.20.00.00.0-1.00.00.0
            Gross margin76.5%47.8%55.6%  -50.9%  
Sales and marketing5.23.81.6     
Research and development0.52.02.72.63.3 7.33.1
General and administrative4.54.34.74.03.12.84.73.5
EBITA-9.4-10.5-9.6-5.6-6.5-4.7-12.0-6.6
            EBITA margin-498.3%-2501.5%-17969.9%  -250.9%  
Amortization of intangibles   1.1    
EBIT-9.4-10.5-9.6-6.8-6.5-4.7-12.0-6.6
            EBIT margin-498.3%-2501.5%-17969.9%  -250.9%  
Pre-tax income-9.2-10.3-9.0-6.7-6.0-3.60.00.0
Income taxes-0.20.0-1.3-0.2-0.30.00.00.0
            Tax rate2.6% 14.4%2.9%5.7%0.0%  
Net income-9.5-10.8-8.2-6.8-6.3-3.6-11.6-1.5
            Net margin-502.2%-2568.6%-15233.8%  -188.7%  
 
Diluted EPS($0.66)($2.10)($0.67)($1.32)($1.80) ($0.42)($0.11)
Shares outstanding (diluted)14.35.112.15.23.5 27.714.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy